User profiles for M. T. Schechter

Martin T. Schechter

Professor of Population and Public Health, University of British Columbia
Verified email at ubc.ca
Cited by 28160

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction

…, W Van Den Brink, C Haasen, MT Schechter… - The British Journal of …, 2015 - cambridge.org
BackgroundSupervised injectable heroin (SIH) treatment has emerged over the past 15
years as an intensive treatment for entrenched heroin users who have not responded to …

Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review

…, S Harrison, DC Marsh, MT Schechter… - … , prevention, and policy, 2019 - Springer
Background Despite ongoing efforts aimed to improve treatment engagement for people with
substance-related disorders, evidence shows modest rates of utilization as well as client-…

Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics

…, P Blanken, C Haasen, J Rehm, MT Schechter… - Journal of Urban …, 2007 - Springer
Since the initial Swiss heroin-assisted treatment (HAT) study conducted in the mid-1990s,
several other jurisdictions in Europe and North America have implemented HAT trials. All of …

Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc

JP Thompson, RH Pearce, MT Schechter, ME Adams… - Spine, 1990 - journals.lww.com
A five-category grading scheme for assessing the gross morphology of midsagittal sections
of the human lumbar intervertebral disc was developed. The ability of three observers to …

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy

…, B Yip, KJP Craib, MV O'shaughnessy, MT Schechter… - Jama, 1998 - jamanetwork.com
Context.—Clinical trials have established the efficacy of antiretroviral therapy with double-
and triple-drug regimens for individuals infected with the human immunodeficiency virus (HIV)…

Needle exchange is not enough: lessons from the Vancouver injecting drug use study

…, ML Rekart, JSG Montaner, MT Schechter… - Aids, 1997 - journals.lww.com
Objective: To describe prevalence and incidence of HIV-1, hepatitis C virus (HCV) and risk
behaviours in a prospective cohort of injecting drug users (IDU). Setting: Vancouver, which …

[HTML][HTML] Spinal bone loss and ovulatory disturbances

JC Prior, YM Vigna, MT Schechter… - New England Journal …, 1990 - Mass Medical Soc
Background. Osteoporosis develops in women with estrogen deficiency and amenorrhea
who lose bone at an accelerated rate. It Is not known to what extent bone loss differs between …

Barriers to use of free antiretroviral therapy in injection drug users

…, MV O'Shaughnessy, JSG Montaner, MT Schechter… - Jama, 1998 - jamanetwork.com
Context.—In British Columbia, human immunodeficiency virus (HIV)–infected persons eligible
for antiretroviral therapy may receive it free but the extent to which HIV-infected injection …

[HTML][HTML] The psychological consequences of predictive testing for Huntington's disease

…, M Bloch, SB Sheps, MT Schechter… - … England Journal of …, 1992 - Mass Medical Soc
Background. Advances in molecular genetics have led to the development of tests that can
predict the risk of inheriting the genes for several adult-onset diseases. However, the …

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

…, K Li, E Wood, MV O'Shaughnessy, MT Schechter - Aids, 2003 - journals.lww.com
Objectives: The explosive and ongoing injecting drug use-related HIV-1 epidemic in Vancouver
continues to receive international attention. This study was conducted to determine how …